Interventional cardiologist Alfred G. Valles, MD, was 50 years old at the time of the accident. According to colleagues, he "strived daily to achieve his vision for world-class care."

Here is a list of all the late-breaking clinical trials being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 annual meeting Oct. 23-26, 2023, in San Francisco.

ACC President Hadley Wilson, MD, explains the big impact four late-breaking studies on intravascular imaging may have on revising PCI guidelines.

The self-expanding valve, already approved by the FDA, was designed with three gold markers to boost implanter efficiency, an updated catheter tip and a more flexible delivery system.

The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns. 

Should interventional cardiologists be using X, the website formerly known as Twitter? A team of specialists explored that very question, sharing its assessment in JSCAI.

Haemonetics expects the deal to increase its short- and long-term revenue. The all-cash transaction should close by January 2024.

Researchers explored data from the first 10 patients treated with a new self-expanding TAVR device from KOKA Lifesciences. After 30 days, there were no patient deaths and only one adverse event.